Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference7%
- Check20 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0, indicating a new release with potential changes behind the scenes but no other substantive content changes detected.SummaryDifference0.2%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing the previous v3.0.1. The 'Back to Top' element was removed as part of the update.SummaryDifference0.4%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.4%
- Check48 days agoChange DetectedThe web page has been updated to include a new facility name and location, enhancing the core content related to the study. Additionally, several sections related to study status and details have been added, which may provide more comprehensive information for users.SummaryDifference100%
- Check63 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.